Resistance of human periodontal ligament fibroblasts to the cytolethal distending toxin of Actinobacillus actinomycetemcomitans

Journal of Periodontology

Volumn 76, Issue 7, 2005, Pages 1189-1201

  Kanno, Fumio ^a   Korostoff, Jonathan ^a   Volgina, Alla ^a   DiRienzo, Joseph M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Actinobacillus actinomycetemcomitans; Cell cycle; Cells, epithelial; Fibroblasts, periodontal; Periodontal diseases pathogenesis; Toxin, cytolethal distending

Indexed keywords

BACTERIAL TOXIN; CYTOLETHAL DISTENDING TOXIN; DOUBLE STRANDED DNA; HOLOTOXIN; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ARTICLE; BACTERIAL VIRULENCE; CELL CYCLE; CELL CYCLE S PHASE; CELL IMMORTALIZATION; CELL LINE; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; EPITHELIUM CELL; FIBROBLAST; FIBROBLAST CULTURE; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; NONHUMAN; PATHOGENESIS; PERIODONTAL DISEASE; PERIODONTAL LIGAMENT; PROTEIN BINDING; PULSED FIELD GEL ELECTROPHORESIS;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; BACTERIAL TOXINS; CELL CYCLE; CELL LINE, TRANSFORMED; CELLS, CULTURED; DNA DAMAGE; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; HELA CELLS; HUMANS; MALE; PERIODONTAL DISEASES; PERIODONTAL LIGAMENT; PROTEIN BINDING; RECOMBINANT PROTEINS; VIRULENCE FACTORS;

EID: 23044446172     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2005.76.7.1189     Document Type: Article

References (45)

1. Johnson WM, Lior H. Response of Chinese hamster ovary cells to a cytolethal distending toxin (CDT) of Escherichia coli and possible misinterpretation as heat-labile (LT) enterotoxin. FEMS Microbiol Lett 1987;43:19-23.
2. Johnson WM, Lior H. A new heat-labile cytolethal distending toxin (CLDT) produced by Escherichia coli isolates from clinical material. Microbial Pathol 1988;4:103-113.
3. Johnson WM, Lior H. A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microbial Pathol 1988;4:115-126.
4. Mooney A, Clyne M, Curran T, Doherty D, Kilmartin B, Bourke B. Campylobacter upsaliensis exerts a cytolethal distending toxin effect on HeLa cells and T lymphocytes. Microbiology 2001;147:735-743.
5. Hickey TE, McVeigh AL, Scott DA, et al. Campylobacter jejuni cytolethal distending toxin mediates release of interleukin-8 from intestinal epithelial cells. Infect Immun 2000;68:6535-6541.
6. Johnson WM, Lior H. Production of Shiga toxin and a cytolethal distending toxin (CLDT) by serogroups of Shigella spp. FEMS Microbiol Lett 1987;48:235-238.
7. Okuda J, Kurazono H, Takeda Y. Distribution of the cytolethal distending toxin A gene (cdtA) among species of Shigella and Vibrio, and cloning and sequencing of the cdt gene from Shigella dysenteriae. Microb Pathol 1995;18:167-172.
8. Cope LD, Lumbley S, Latimer JL, et al. A diffusible cytotoxin of Haemophilus ducreyi. Proc Natl Acad Sci (USA) 1997; 94:4056-4061.
9. Chien CC, Taylor NS, Ge Z, Schauer DB, Young VB, Fox JG. Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp. J Med Microbiol 2000;49:525-534.
10. Young VB, Knox KA, Schauer DB. Cytolethal distending toxin sequence and activity in the enterohepatic pathogen Helicobacter hepaticus. Infect Immun 2000;68:184-191.
11. Kostia S, Veijalainen P, Hirvi U, Hanninen ML. Cytolethal distending toxin B gene (cdtB) homologues in taxa 2, 3 and 8 and in six canine isolates of Helicobacter sp. flexispira. J Med Microbiol 2003;52:103-108.
12. Mayer MPA, Bueno LC, Hansen EJ, DiRienzo JM. Identification of a cytolethal distending toxin gene locus and features of a virulence-associated region in Actinobacillus actinomycetemcomitans. Infect Immun 1999;67: 1227-1237.
13. 2 arrest in human T cells. J Immunol 1999; 162:4773-4780.
14. Sugai M, Kawamoto T, Pérès SY, et al. Cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect Immun 1998;66:5008-5019.
15. Pickett CL, Cottle DL, Pesci EC, Bikah G. Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes. Infect Immun 1994;62:1046-1051.
16. Scott DA, Kaper JB. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect Immun 1994;62:244-251.
17. Comayras C, Tasca C, Pérès SY, Ducommun B, Oswald E, De Rycke J. Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G2/M transition by preventing cdc2 protein kinase dephosphorylation and activation. Infect Immun 1997;65:5088-5095.
18. Escalas N, Davezac N, De Rycke J, Baldin V, Mazars R, Ducommun B. Study of the cytolethal distending toxin-induced cell cycle arrest in HeLa cells: Involvement of the CDC25 phosphatase. Exper Cell Res 2000;257:206-212.
19. Pérès SY, Marchès O, Daigle F, et al. A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase. Mol Microbiol 1997;24:1095-1107.
20. 2-phase cell cycle block. Infect Immun 1998;66:1934-1940.
21. Akifusa S, Poole S, Lewthwaite J, Henderson B, Nair SP. Recombinant Actinobacillus actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis. Infect Immun 2001;69:5925-5930.
22. Cortes-Bratti X, Chaves-Olarte E. Lagergard T, Thelestam M. The cytolethal distending toxin from the chancroid bacterium Haemophilus ducreyi induces cell-cycle arrest in the G2 phase. J Clin Invest 1999;103:107-115.
23. DiRienzo JM, Song M, Wan LSY, Ellen RP. Kinetics of KB and HEp-2 cell responses to an invasive, cytolethal distending toxin producing strain of Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 2002;17: 245-251.
24. Stevens MK, Latimer JL, Lumbley SR, et al. Characterization of a Haemophilus ducreyi mutant deficient in expression of cytolethal distending toxin. Infect Immun 1999;67:3900-3908.
25. Gelfanova V, Hansen EJ, Spinola SM. Cytolethal distending toxin of Haemophilus ducreyi apoptotic death of Jurkat T cells. Infect Immun 1999;67:6394-6402.
26. Belibasakis G, Johansson A, Wang Y, et al. Inhibited proliferation of human periodontal ligament cells and gingival fibroblasts by Actinobacillus actinomycetemcomitans: Involvement of the cytolethal distending toxin. Eur J Oral Sci 2002; 110:366-373.
27. Deng K, Hansen EJ. A CdtA-CdtC complex can block killing of HeLa cells by Haemophilus ducreyi cytolethal distending toxin. Infect Immun 2003;71:6633-6640.
28. Hassane DC, Lee RB, Pickett CL. Campylobacter jejuni cytolethal distending toxin promotes DNA repair responses in normal human cells. Infect Immun 2003;71:541-545.
29. Elwell CA, Dreyfus LA. Dnase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol Microbiol 2000;37:952-963.
30. Frisan T, Cortes-Bratti X, Chaves-Olarte E, Stenerlow B, Thelestam M. The Haemophilus ducreyi cytolethal distending toxin induces DNA double-strand breaks and promotes ATM-dependent activation of RhoA. Cell Microbiol 2003;5:695-707.
31. Lara-Tejero M, Galán JE. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 2000;290:354-357.
32. Pickett CL, Whitehouse CA. The cytolethal distending toxin family. Trends Microbiol 1999;7:292-297.
33. Cortes-Bratti X, Karlsson C, Lagergard T, Thelestam M, Frisan T. The Haemophilus ducreyi cytolethal distending toxin induces cell cycle arrest and apoptosis via the DNA damage checkpoint pathways. J Biol Chem 2001; 276:5296-5302.
34. Henderson B, Nair SP, Ward JM, Wilson M. Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans. Annu Rev Microbiol 2003;57:29-55.
35. Fabris AS, DiRienzo JM, Wikstrom M, Mayer MPA. Detection of cytolethal distending toxin activity and cdt genes in Actinobacillus actinomycetemcomitans isolates from geographically diverse populations. Oral Microbiol Immunol 2002;17:231-238.
36. Tan K-S, Song K-P, Ong G. Cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Occurrence and association with periodontal disease. J Periodontal Res 2002;37:268-272.
37. Lekic PC, Pender N, McCulloch CA. Is fibroblast heterogeneity relevant to the health, diseases, and treatments of periodontal tissues? Crit Rev Oral Biol Med 1997;8:253-268.
38. Mao X, DiRienzo JM. Functional studies of the recombinant subunits of a cytolethal distending holotoxin. Cell Microbiol 2002;4:245-255.
39. Somerman MJ, Archer SY, Imm GR, Foster RA. A comparative study of human periodontal ligament cells and gingival fibroblasts in vitro. J Dent Res 1988;67:66-70.
40. Gilchrist EP, Moyer MP, Shillitoe EJ, Clare N, Murrah VA. Establishment of a human polyclonal oral epithelial cell line. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000;90:340-347.
41. Vindelov LL. Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions: A new method for rapid isolation and staining of nuclei. Virchows Arch B Cell Pathol 1977;24:227-242.
42. Pickett CL, Pesci EC, Cottle DL, Russell G, Erdem AN, Zeytin H. Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB genes. Infect Immun 1996;64:2070-2078.
43. Okuda J, Fukumoto M, Takeda Y, Nishibuchi M. Examination of diarrhea genicity of cytolethal distending toxin: Suckling mouse response to the products of the cdtABC genes of Shigella dysenteriae. Infect Immun 1997;65:428-433.
44. Bueno LC, Mayer MPA, DiRienzo JM. Relationship between conversion of localized juvenile periodontitis-susceptible children from health to disease and Actinobacillus actinomycetemcomitans leukotoxin promoter structure. J Periodontol 1998;69:998-1007.
45. Helgeland K, Nordby Ø. Cell cycle-specific growth inhibitory effect on human gingival fibroblasts of a toxin isolated from the culture medium of Actinobacillus actinomycetemcomitans. J Periodontal Res 1993;28:161-165.